NPI registry status
Active
2026 NPPES data Endocrinology, Diabetes & Metabolism Physician NPI 1841672110
Verify on CMS → Sophia Galustian
Endocrinology, Diabetes & Metabolism Physician in Kansas City, Missouri.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 7,852 in Endocrinology, Diabetes & Metabolism Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
763
Medicare Part D claims · 144 beneficiaries · Endocrinology, Diabetes & Metabolism Physician avg: 3K
Generic prescribing
51%
generic claims · 43% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
91.1/100
▲ 8 pts above national avg 83.1 · Exceptional
Source: CMS Medicare Part D Prescriber Public Use File, 2023
Compiled from official public sources by the PlainDoctor editorial team.
What the federal data shows
Sophia Galustian reported a CMS MIPS final score of 91.1/100 - above the 83.1 national average - and filed 763 Medicare Part D claims in 2023.
- 91.1/100
- MIPS score · +8 vs avg
- 763
- Part D claims, 2023
- 51%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Sophia Galustian's MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure
91 Top 37% higher than 63% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Sophia Galustian sits
This provider among endocrinology, diabetes & metabolism physician peers
Across the 2,521 endocrinology, diabetes & metabolism physician providers who report both Medicare Part D prescribing and a MIPS quality score, Sophia Galustian writes more Part D claims than 21% of them and scores higher on MIPS quality than 66% - placing this provider in the lower-volume, high-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Part D claim volume vs MIPS quality, by specialty percentile
Each dot is one endocrinology, diabetes & metabolism physician peer from a representative sample of 60; the gold marker is Sophia Galustian. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
✓
Board certification likely (heuristic, not verified)
Sophia Galustian practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Sophia Galustian?
High performer (top quartile)Primary specialty
Endocrinology, Diabetes & Metabolism Physician
Medicare Part D claims
763 71% vs specialty avg
MIPS final score
91.1/100 8 pts vs avg
Specialty distribution in Missouri
How Endocrinology, Diabetes & Metabolism Physician compares to other specialties among Missouri providers
Medicare quality performance, MIPS
Sophia Galustian's 2023 MIPS final score plotted against the Endocrinology, Diabetes & Metabolism Physician national average
- MIPS Final Score
- 91.1/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Endocrinology, Diabetes & Metabolism Physician) - 91.1/100 vs national avg 83.1
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Sophia Galustian appears in the CMS NPPES registry as a Endocrinology, Diabetes & Metabolism Physician provider at 2411 HOLMES ST, Kansas City, MO, 64108, with a listed phone of (816) 235-5172. NPI 1841672110 was issued on 06/23/2015.
Medicare Part D records for calendar year 2023 show 763 prescription claims written by this provider, covering 144 Medicare beneficiaries and totaling roughly $292K in drug spend, split 43% brand-name and 51% generic by claim count. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 91.1/100 for the 2023 performance year (Quality 68.7, Cost 98.4), compared with the national average of 83.1.
Endocrinology, Diabetes & Metabolism Physician is a mid-sized specialty nationwide, with 7,852 enrolled providers across 54 states and an average of 2,639 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1841672110 |
|---|---|
| Specialty | Endocrinology, Diabetes & Metabolism Physician |
| Gender | Female |
| NPI Issued | 06/23/2015 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
91.1164
Final Score
Avg: 83.1
68.7112
Quality
98.4291
Cost
100
Promoting Interoperability
Reporting: Group practice
Hospital and facility affiliations
Facilities where Sophia Galustian bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Bergen County Improvement Authority
Paramus, NJ
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Brand vs generic prescribing mix · Above average
Sophia Galustian - brand share 43.0%
Endocrinology, Diabetes & Metabolism Physician average
43% brand-name claims vs 51% generic, on 763 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
763
Total Claims
$292K
Total Drug Cost
144
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 1,650
- Total Day Supply
- 49,022
- Brand vs Generic
- 43% brand / 51% generic
- Brand Drug Cost
- $279K
- Generic Drug Cost
- $9K
Patient Demographics
- Average Patient Age
- 70.5 years
- Avg HCC Risk Score
- 1.44
- Gender Split
- 60% female / 40% male
- Age Distribution
- <65: 22, 65-74: 74, 75-84: 37, 85+: 11
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Sophia Galustian prescribes most
Top Medicare Part D drugs by claim count, 2023
- Metformin Hcl
Metformin Hcl
91 claims
- Levothyroxine Sodium
Levothyroxine Sodium
76 claims
- Trulicity
Trulicity
46 claims
- Atorvastatin Calcium
Atorvastatin Calcium
40 claims
- Tresiba Flextouch …
Tresiba Flextouch U-100
40 claims
- Humalog Kwikpen U-… 30
Humalog Kwikpen U-100
30 claims
- Jardiance 29
Jardiance
29 claims
- Ozempic 29
Ozempic
29 claims
| Drug | Claims |
|---|---|
| Metformin Hcl | 91 |
| Levothyroxine Sodium | 76 |
| Trulicity Dulaglutide | 46 |
| Atorvastatin Calcium | 40 |
| Tresiba Flextouch U-100 Insulin Degludec | 40 |
| Humalog Kwikpen U-100 Insulin Lispro | 30 |
| Jardiance Empagliflozin | 29 |
| Ozempic Semaglutide | 29 |
| Novolog Flexpen Insulin Aspart | 20 |
| Alendronate Sodium | 19 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
More Endocrinology, Diabetes & Metabolism Physician in MO →
All providers in Missouri →
Compare specialties →
Endocrinology, Diabetes & Metabolism Physician Overview
How Sophia Galustian fits within the Endocrinology, Diabetes & Metabolism Physician landscape nationally.
7,852
Endocrinology, Diabetes & Metabolism Physician Providers in US
54
States with Endocrinology, Diabetes & Metabolism Physician
2,639
Avg Claims per Provider
Sophia Galustian's 763 claims are below the specialty average of 2,639.
Nearby Endocrinology, Diabetes & Metabolism Physician Providers in Missouri
Other clinicians with the same primary specialty enrolled in Missouri, drawn from the same CMS NPPES roster as Galustian.
Dr. Ehab Abdelgyed
M.B.B.CH
Joplin, MO
Dr. Pratibha Abraham
MD
Fenton, MO
Dr. Maha Abu Kishk
M.D.
Kansas City, MO
Dr. Sonya Addison
M.D.
Columbia, MO
Dr. Huda Al-Bahadili
MD
Saint Louis, MO
Compare Endocrinology, Diabetes & Metabolism Physician nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the Missouri medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Endocrinology, Diabetes & Metabolism Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
How to Find a Doctor
Step-by-step guide to choosing a provider
Verify Credentials
Check NPI, board certification & license status
Medical Specialties Explained
Who treats what and how specialties differ
Understanding Medicare Claims Data
What prescribing data reveals about a provider
In-Network vs Out-of-Network
How insurance networks affect your costs
Telehealth Guide
Virtual care options and coverage in 2026
Explore Missouri
Frequently Asked Questions
What is Sophia Galustian's specialty? ▼
Sophia Galustian specializes in Endocrinology, Diabetes & Metabolism Physician and practices in Kansas City, Missouri.
How much does Sophia Galustian prescribe under Medicare Part D? ▼
In 2023, Sophia Galustian wrote 763 Medicare Part D claims totaling $292K in drug costs for 144 beneficiaries.
What is Sophia Galustian's Medicare quality score? ▼
Sophia Galustian has a CMS MIPS Final Score of 91.1/100 (Quality: 68.7, Cost: 98.4). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Sophia Galustian located? ▼
Sophia Galustian is located at 2411 HOLMES ST, Kansas City, MO, 64108. Phone: (816) 235-5172.
What is Sophia Galustian's NPI number? ▼
Sophia Galustian's National Provider Identifier (NPI) is 1841672110, issued on 06/23/2015.
Does Sophia Galustian prescribe more brand-name or generic drugs? ▼
Sophia Galustian's prescribing is 43% brand-name and 51% generic drugs by claim count, with $279K in brand drug costs.
How many Endocrinology, Diabetes & Metabolism Physician providers are there in the US? ▼
There are 7,852 Endocrinology, Diabetes & Metabolism Physician providers across 54 states in the US. The average Endocrinology, Diabetes & Metabolism Physician provider writes 2,639 Medicare Part D claims per year.
What drugs does Sophia Galustian prescribe most often? ▼
Based on 2023 Medicare Part D data, Sophia Galustian's most frequently prescribed drugs include Metformin Hcl, Levothyroxine Sodium, Trulicity. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Sophia Galustian accept Medicare? ▼
Sophia Galustian appears in CMS Medicare data with 763 Part D claims and 144 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Sophia Galustian's credentials? ▼
Sophia Galustian's NPI is 1841672110. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Compiled from official public sources by the PlainDoctor editorial team.